Biogen's next-generation fumaric acid product, Vumerity, has been approved by the UK MHRA
Time of Update: 2022-02-25
CompilenewbornBiogen Vumerity (diroximel fumarate), a next-generation oral fumarate therapy for the treatment of relapsing-remitting multiple sclerosis (RRMS), has been approved by the Medicines and Healthcare Products Administration (MHRA) in the United Kingdom .
Astellas Prograf U.S. Approves New Indication
Time of Update: 2021-07-31
This FDA approval marks the first approval of an immunosuppressant drug to prevent rejection in adult and pediatric patients undergoing lung transplantation .
Hengrui Medicine: Docetaxel injection passed the quality and efficacy consistency evaluation of generic drugs
Time of Update: 2021-03-29
Docetaxel is a paclitaxel anti-tumor drug, which plays an anti-tumor effect by interfering with the microtubule network necessary for cell mitosis and interphase cell function .
The evaluation of modified drugs and salt-based drugs is generally considered for comments
Time of Update: 2021-02-07
3. Quality control: systematic analysis compares the differences in the quality of the preparation with the original dosage form, focusing on: the solubility curve of the drug in multiple media; stability test: focus on traits, dissolved curves, related substances (especially new impurities), content determination and other items.
Mylan and Puqiang merge after the new first exposure! What are the meanings? Pfizer, BMS, Teva
Time of Update: 2020-06-01
"The name Viatris conveys the traditional strength sympathies that our two companies share and our shared goal of delivering high-quality medicines to as many patients as possible," said Michael Goett